Cancer Center at Illinois (CCIL) Deputy Director Paul Hergenrother was recently named a 2023 National Cancer Institute (NCI) Outstanding Investigator. The prestigious NCI Outstanding Investigator Award (OIA) recognizes the outstanding research performance of cancer...
Paul Hergenrother
Paul J. Hergenrother, Ph.D., is a Professor of Chemistry and an Affiliate in Biochemistry, and the Kenneth L. Rinehart Jr. Endowed Chair in Natural Products Chemistry. The Hergenrother laboratory seeks to use small molecules to identify and validate novel targets for...
Research & Impact: A Look Back at 2023
This year proved to be one of success and growth for the Cancer Center at Illinois (CCIL). Below you'll find 10 of the year's biggest moments in research, education, and community engagement, meet our new members, and have the chance to dive deeper into our efforts....
Unprecedented Compound Takes a Step Toward Breast Cancer Clinical Trials
Cancer Center at Illinois (CCIL) researchers David Shapiro and Paul HergenrotherEstrogen receptor-positive breast cancer is the most common form of breast cancer, affecting approximately 75% of breast cancer patients. In advanced and metastatic form, it is lethal,...
2023 Cancer Center Annual Retreat
The 2023 Cancer Center Annual Retreat is an important opportunity to learn about significant Cancer Center at Illinois advancements over the past year, hear examples of the amazing research happening on our campus, and explore the multiple opportunities available to...
Team Identifies Key Driver of Cancer Cell Death Pathway That Activates Immune Cells
The team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate student Junyao Zhu and molecular and integrative physiology professor Erik Nelson. Photo by Fred ZwickyCHAMPAIGN, Ill. —...
First test of anti-cancer agent PAC-1 in human clinical trials shows promise
Illinois professor of veterinary clinical medicine Dr. Timothy Fan, left, and chemistry professor Paul Hergenrother. The U. of I. team found that the compound PAC-1 has therapeutic potential in pet dogs with spontaneously occurring cancers. The animal studies set the...
Cancer Center at Illinois announces 2022 cancer research grant recipients
Top, from left to right: Martin Burke, Christopher Gaulke, and Catherine Murphy.Bottom, from left to right: Joaquín Rodríguez López, Emad Tajkhorshid, and Kai Zhang.The Cancer Center at Illinois is proud to announce the selection of nine interdisciplinary cancer...
Cancer Center at Illinois scientists improve BRAF inhibitor for better blood brain barrier penetration
Timothy Fan and Paul Hergenrother.Urbana, Ill. – Cancers that begin in the brain, or start elsewhere in the body and spread to it, are notoriously difficult to treat. Illinois researchers in Cancer Center at Illinois labs are looking to improve those odds by...
Illini 4000 visits CCIL on Ride Through America
Sam Corley, undergraduate, Computer ScienceUrbana, Ill. — The Illini 4000 is a non-profit organization whose members are University of Illinois Urbana-Champaign students that are documenting the American cancer experience through The Portraits Project, raising funds...